archive-ie.com » IE » N » NCPE.IE

Total: 381

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • C | National Centre for Pharmacoeconomics
    M N O P Q R S T U V W Clinical outcome An outcome of major clinical importance that is defined on the basis of the disease being studied e g fracture in osteoporosis relapse rates Clinical significance A conclusion that an intervention has an effect that is of practical meaning to patients and health care providers Effects identified as statistically significant are not always clinically significant because the effect is small or the outcome is not important Clinical trial A carefully controlled and monitored research study on human subjects or patients evaluating one or more health interventions Each trial is designed to answer specific scientific questions Comparative effectiveness The ability of one treatment relative to another to demonstrate clinical effectiveness Comparator the alternative to which the intervention is compared Cost the value of opportunity forgone as a result of engaging resources in an activity Cost benefit analysis CBA An economic evaluation comparing alternative interventions in which costs and outcomes are quantified using the same monetary units Cost consequences analysis An economic evaluation in which the components of costs and consequences health outcomes adverse effects etc are measured and presented in their natural units without any attempt to aggregate

    Original URL path: http://www.ncpe.ie/category/glossary/c/ (2015-10-30)
    Open archived version from archive


  • D | National Centre for Pharmacoeconomics
    treatment for a particular clinical problem to determine which is optimal Decision tree A graphical framework for representing alternatives for use in decision analysis Deterministic sensitivity analysis DSA A method of capturing the level of uncertainty in the results of decision analysis which varies variables one at a time one way sensitivity analysis or two or more at a time multi way sensitivity analysis Diagnosis Related Group DRG A patient classification scheme that provides a clinically meaningful way of relating the types of patients treated in a hospital to the resources required by the hospital Direct costs The fixed and variable costs of all resources goods services etc consumed in the provision of an intervention as well as any consequences of the intervention such as adverse effects or goods or services induced by the intervention includes direct medical costs and direct nonmedical costs such as transportation or child care Direct medical costs A medical cost that varies directly with the provision of a health care intervention e g physician salaries Direct non medical costs A non medical cost associated with provision of medical services e g transportation of a patient to a hospital Discount rate The interest rate used to

    Original URL path: http://www.ncpe.ie/category/glossary/d-glossary/ (2015-10-30)
    Open archived version from archive

  • E | National Centre for Pharmacoeconomics
    Economic evaluation The comparison of alternative courses of action in terms of their costs and consequences to inform and support the decision making process Economic model a framework for bringing together different types of data from a range of sources to describe the patient pathway and the choices and consequences for the interventions under study Modelling may be used to combine different data sets changing the information collected from a clinical trial into a form that can be used to extrapolate short term clinical data to longer term to link intermediate with final endpoints to generalise from clinical trial settings to routine practice and to estimate the relative effectiveness of technologies where these have not been directly compared in clinical trials Effectiveness The evaluation of benefit or risk in a standard clinical setting using outcomes measuring issues of importance to patients Efficacy The evaluation of benefit or risk in a defined population in controlled or ideal circumstances e g in a laboratory setting under research conditions EVPI Expected value of perfect information describes the maximum amount a decision maker would be willing to pay in order to obtain perfect information where perfect information would allow them to make a choice

    Original URL path: http://www.ncpe.ie/category/glossary/e/ (2015-10-30)
    Open archived version from archive

  • H | National Centre for Pharmacoeconomics
    of intervention on health e g a clinical procedure health policy or program etc Health technology assessment HTA The systematic evaluation of properties effects and or impacts of health care technology It may address the direct intended consequences of technologies as well as their indirect unintended consequences Its main purpose is to inform technology related policymaking in healthcare HTA is conducted by interdisciplinary groups using explicit analytical frameworks drawing from

    Original URL path: http://www.ncpe.ie/category/glossary/h/ (2015-10-30)
    Open archived version from archive

  • I | National Centre for Pharmacoeconomics
    S T U V W Incremental cost effectiveness ratio ICER The additional cost of an intervention as compared with the comparator divided by the difference in effect or patient outcome between the interventions e g additional cost per QALY Indirect costs The cost of time lost from work or leisure and decreased productivity due to disease disability or death In cost accounting refers to costs that cannot be attributed to

    Original URL path: http://www.ncpe.ie/category/glossary/i/ (2015-10-30)
    Open archived version from archive

  • M | National Centre for Pharmacoeconomics
    related quality of life weights are statistically predicted from one or more other measures Markov Model A type of quantitative modelling that involves a specified set of mutually exclusive and exhaustive states e g of a given health status and for which there are transition probabilities of moving from one state to another including remaining in the same state Typically states have a uniform time period and transition probabilities remain

    Original URL path: http://www.ncpe.ie/category/glossary/m/ (2015-10-30)
    Open archived version from archive

  • N | National Centre for Pharmacoeconomics
    Flowchart Submission Templates Pharmacoeconomic Evaluations Drugs Vaccines Diagnostics and Other Technologies Publications Peer Reviewed Papers Abstracts Reports Research Drug Utilisation Research Pharmacoeconomic Research ICORN Education Glossary N In this Section About Us Current Staff News Glossary Contact Us Vacancies A B C D E H I M N O P Q R S T U V W Net benefit Benefit in monetary units minus total cost in monetary units Terms

    Original URL path: http://www.ncpe.ie/category/glossary/n/ (2015-10-30)
    Open archived version from archive

  • O | National Centre for Pharmacoeconomics
    ICORN Education Glossary O In this Section About Us Current Staff News Glossary Contact Us Vacancies A B C D E H I M N O P Q R S T U V W Odds ratio OR A measure of treatment effect that compares the probability of a type of outcome in the treatment group with the outcome of a control group i e Pt 1 Pt Pc 1 Pc

    Original URL path: http://www.ncpe.ie/category/glossary/o/ (2015-10-30)
    Open archived version from archive